Making Drugs From Yeast

Antheia CEO Christina Smolke brews up new pharmaceuticals…
Join the Movement to Build a Century-Defining Technology

Synthetic biology isn’t a household name – yet. But it will be soon, because it’s a thriving, innovative field that’s solving some of humanity’s greatest and most pressing challenges…
Antheia to access Ginkgo’s enzyme screening and design technology

Ginkgo Bioworks, a Boston-based cell-programming specialist, will deploy its high-throughput enzyme design and screening technology to help the synthetic biology firm Antheia broaden its pipeline of drug active ingredients…
Brewing up plant-inspired medicines

Antheia reconstructs complex biochemical pathways in yeasts to speed up production of natural product-based drugs…
On Heels of $17 Billion SPAC Deal, Ginkgo Inks Collab with Synthetic Biology Firm

California synthetic biology firm Antheia has joined forces with Boston-based biotech company Ginkgo Bioworks to strengthen its efforts to develop and produce essential medicines to treat a wide range of diseases…
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to accelerate the development…
Out to revamp plant-based drug manufacturing, Antheia locks in partnership with synthetic biology…

With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy, synthetic biology upstart Antheia…
Using Yeast to Make Medication

Yeast plays an important role in food and beverage production, but its properties also make it an excellent factory for many compounds, including medication…
Three plant-based pharmaceuticals: taxol, scopolamine and buprenorphine

Over the last 150 years, the pharmaceutical industry has focused on decoupling the production of medicinal compounds from their sources in the natural world, which are susceptible to unpredictable swings in supply due to natural events like wildfires, drought or floods…
The pandemic has exposed our broken pharma supply chain. Synthetic biology and brewer’s yeast could fix it.

Covid-19 has depleted stockpiles of essential medicines in the U.S., straining our supply chains and hobbling the treatment of critically ill patients.